Drawing for JUVANTIA PHARMA

USPTO serial 75740610

JUVANTIA PHARMA

Reviewed by CopyMark Law Group

Reg. 2533320Status 710
Filing date
Status date
Registration date
Jan 29, 2002
Examiner
EDWARDS, ALICIA COLLINS
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with JUVANTIA PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001CHEMICAL DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC USE; LIBRARIES OF CHEMICAL DIAGNOSTIC COMPOUNDS FOR RESEARCH USE; CHEMICAL REAGENTS FOR RESEARCH USE; CHEMICAL DIAGNOSTIC SUBSTANCES AND PREPARATIONS FOR USE IN ANALYSES IN LABORATORIES FOR RESEARCH USE; BIOLOGICAL DIAGNOSTIC PREPARATIONS FOR RESEARCH USESECTION 8 - CANCELLED
005THERAPEUTICALLY ACTIVE DIAGNOSTIC PREPARATIONS FOR MEDICAL LABORATORY USE; LIBRARIES OF THERAPEUTICALLY ACTIVE CHEMICAL DIAGNOSTIC COMPOUNDS FOR MEDICAL LABORATORY USE; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM AND VASCULAR DISORDERS; VETERINARY PREPARATIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM AND VASCULAR DISORDERS; BIOLOGICAL DIAGNOSTIC PREPARATIONS FOR CLINICAL MEDICAL OR VETERINARY LABORATORY PURPOSESSECTION 8 - CANCELLED
042SCIENTIFIC AND INDUSTRIAL RESEARCH, PARTICULARLY RESEARCH RELATING TO PHARMACEUTICALS AND RECEPTOR STUDIES; CHEMICAL ANALYSIS AND RESEARCH, PARTICULARLY PHARMACEUTICAL SCREENING ASSAYS AND OTHER BIOAFFINITY ASSAYS; PRE-SYNTHETIC DRUG DESIGN FOR OTHERS; DESIGN FOR OTHERS IN THE FIELD OF MOLECULE MODELINGSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 31, 2012CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Nov 10, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 11, 2008C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 1, 2008PLGLASSIGNED TO PARALEGAL
Jan 29, 2008E815TEAS SECTION 8 & 15 RECEIVED
Apr 9, 2007CFITCASE FILE IN TICRS
Jan 29, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 6, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 17, 2001NPUBNOTICE OF PUBLICATION
Feb 15, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 11, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2000CNSLLETTER OF SUSPENSION MAILED
Jul 6, 2000CNEAEXAMINER'S AMENDMENT MAILED
Mar 30, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 1999DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance